13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q1 2025. See the latest, Q2 2026 →
Reported value
$1.57T
−6.5% on the quarter before
Positions
5,285
317 new · 560 sold out
Top 10
33.3%
of the value
Est. gain
−$97.66B
on stocks held all quarter
Est. return
−6.2%
on those stocks since Q4 2024
Positions as of Mar 31, 2025, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 44% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.
Largest buys
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Fidelity Merrimack Str Tr~$3.90BAdded · 0.2% → 0.4%+89,593,223 shares
- Berkshire Hathaway Inc Del~$2.17BAdded · 0.3% → 0.5%+4,075,824 shares
- Amazon~$2.13BAdded · 4.3% → 4.1%+11,170,767 shares
- Alibaba~$2.05BAdded · 0.0% → 0.1%+15,500,090 shares
- Gilead Sciences Inc~$2.04BAdded · 0.2% → 0.4%+18,223,410 shares
- Schwab Charles Corp~$1.74BAdded · 0.0% → 0.2%+22,278,677 shares
- Spotify Technology S A~$1.67BAdded · 0.1% → 0.2%+3,043,677 shares
- Lululemon Athletica Inc~$1.45BAdded · 0.2% → 0.3%+5,110,541 shares
- Broadcom~$1.44BAdded · 1.3% → 1.1%+8,594,898 shares
- Netflix~$1.34BAdded · 1.1% → 1.3%+1,434,003 shares
Largest sells
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alphabet~$4.21BCut · 2.8% → 2.2%−27,253,569 shares
- Unitedhealth Group Inc~$3.09BCut · 0.9% → 0.8%−5,903,163 shares
- Apple~$3.01BCut · 5.1% → 4.7%−13,540,794 shares
- Alphabet~$2.02BCut · 1.3% → 1.0%−12,902,988 shares
- Eli Lilly~$1.71BCut · 1.4% → 1.5%−2,066,580 shares
- Salesforce~$1.56BCut · 0.5% → 0.3%−5,814,594 shares
- Danaher Corporation~$1.35BCut · 0.3% → 0.2%−6,585,239 shares
- Eaton Corp Plc~$1.18BCut · 0.3% → 0.2%−4,334,208 shares
- Tesla~$1.15BCut · 0.8% → 0.5%−4,448,041 shares
- Intra-Cellular Therapies Inc~$1.11BCut · 0.1% → 0.0%−8,414,172 shares
Holdings
As of Mar 31, 2025. Changes are in shares against Dec 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaCOM · shares −0.2% · price −19.3% | 6.9% | $108.59B | −$25.96B | ||||||||
| MetaCL A · shares −0.8% · price −1.6% | 5.0% | $77.91B | −$1.24B | ||||||||
| MicrosoftCOM · shares −1.5% · price −10.9% | 4.7% | $73.05B | −$8.97B | ||||||||
| AppleCOM · shares −4.0% · price −11.3% | 4.7% | $72.88B | −$9.28B | ||||||||
| AmazonCOM · shares +3.4% · price −13.3% | 4.1% | $64.62B | −$9.57B | ||||||||
| AlphabetCAP STK CL A · shares −11% · price −18.3% | 2.2% | $34.20B | −$7.67B | ||||||||
| Berkshire Hathaway Inc DelCL A · shares −0.8% · price +17.3% | 1.7% | $26.55B | +$3.91B | ||||||||
| Eli LillyCOM · shares −6.8% · price +7.0% | 1.5% | $23.51B | +$1.53B | ||||||||
| NetflixCOM · shares +6.9% · price +4.6% | 1.3% | $20.82B | +$860.8M | ||||||||
| Visa Inc.COM CL A · shares +3.1% · price +10.9% | 1.3% | $20.04B | +$1.91B | ||||||||
| BroadcomCOM · shares +9.2% · price −27.8% | 1.1% | $17.06B | −$6.01B | ||||||||
| Exxon Mobil CorpCOM · shares −3.0% · price +10.6% | 1.1% | $16.86B | +$1.61B | ||||||||
| AlphabetCAP STK CL C · shares −11% · price −18.0% | 1.0% | $16.42B | −$3.60B | ||||||||
| Wells Fargo Co NewCOM · shares +1.1% · price +2.2% | 0.94% | $14.74B | +$314.7M | ||||||||
| Boston Scientific CorpCOM · shares −2.9% · price +12.9% | 0.83% | $12.97B | +$1.49B | ||||||||
| Ge AerospaceCOM NEW · shares −4.2% · price +20.0% | 0.82% | $12.81B | +$2.14B | ||||||||
| Unitedhealth Group IncCOM · shares −20% · price +3.5% | 0.81% | $12.68B | +$433.3M | ||||||||
| MastercardCL A · shares +2.4% · price +4.1% | 0.80% | $12.50B | +$479.9M | ||||||||
| Jpmorgan Chase & Co.COM · shares −2.5% · price +2.3% | 0.74% | $11.53B | +$262.8M | ||||||||
| Costco Whsl Corp NewCOM · shares +0.6% · price +3.2% | 0.57% | $9.00B | +$279.1M | ||||||||
| TSMCSPONSORED ADS · shares −11% · price −15.9% | 0.55% | $8.63B | −$1.64B | ||||||||
| Bank America CorpCOM · shares +5.2% · price −5.1% | 0.54% | $8.49B | −$429.2M | ||||||||
| TeslaCOM · shares −13% · price −35.8% | 0.50% | $7.83B | −$4.37B | ||||||||
| Marvell Technology IncCOM · shares −4.7% · price −44.3% | 0.49% | $7.63B | −$6.05B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +41% · price +17.5% | 0.47% | $7.42B | +$781.1M | ||||||||
| Total · 5,285 positions | 100% | $1.57T | −$97.66B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2024 to Q1 2025: 4,797 stocks held throughout, down $97.66B (−6.2%).
- Berkshire Hathaway Inc Del+$3.91B+17%
- Ge Aerospace+$2.14B+20%
- Visa Inc.+$1.91B+11%
- Exxon Mobil Corp+$1.61B+11%
- Eli Lilly+$1.53B+7%
- Alphabet−$7.67B−18%
- Microsoft−$8.97B−11%
- Apple−$9.28B−11%
- Amazon−$9.57B−13%
- Nvidia−$25.96B−19%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 30 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |